1 active not recruiting, 1 completed, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Withdrawn 1 |
Follow Cordgenics, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer ChemoID Assay, Standard Chemotherapy - Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer | Phase 3 | Active not recruiting | Cordgenics, LLC | 150 | 2019-07-26 | 2024-08-22 |
| Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer ChemoID assay, Chemotherapy - Recurrent Ovarian Cancer | Phase 3 | Withdrawn | Cordgenics, LLC | 2018-08-01 | 2025-02-12 | |
| Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma ChemoID assay, Chemotherapy - Recurrent Glioblastoma | Phase 3 | Completed | Cordgenics, LLC | 78 | 2018-05-20 | 2025-04-15 |
Ovarian Neoplasms (2) · Brain Neoplasms (1) · Glioblastoma (1)
Drug Therapy (3)
United States (3)
Kelly J Wilkinson, MD (1) · Thomas Herzog, MD (1) · Tulika Ranjan, MD (1)